Editorial: Lectins from plants, algae, fungi, bacteria and animal therapeutic tools for SARS-CoV-2 and other pathogenic enveloped viruses, in a “one-health” perspective
Frontiers in Cellular and Infection Microbiology · 2023
DOI: 10.3389/fcimb.2023.1139691 ↗Kurz gefasst
Editorial in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2023. Verfasst von Els J M Van Damme und 1 weiteren Autor:innen. Beteiligte Einrichtung: Biotechnology, Ghent University, Ghent, Belgium. Hauptthemen laut MEDLINE: Lectins, COVID-19. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 3 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Editorial on the Research TopicLectins from plants, algae, fungi, bacteria and animals as potential ther- apeutic tools for SARS-CoV-2 and other pathogenic enveloped viruses, in a "one-health" perspective Lectins or carbohydrate-binding agents (CBAs) from diverse sources including plants, algae, fungi, cyanobacteria and animals, can recognize the glycan chains decorating pathogenic enveloped viruses, and consequently offer an interesting alternative to antibodies and antiviral drugs for combating viral infections.Most of the pathogenic enveloped viruses are highly N-glycosylated and exhibit surface glycoproteins containing different types of N-glycans, including complex-type glycans, high-mannose-or oligomannoside-type glycans, and hybrid-type glycans, representing potential targets for lectins with different carbohydrate-binding specificities (Barre et al., 2022).In this regard, the perspective paper from Maier, demonstrated that natural cyanovirin-N (CV-N), the mannose-specific lectin from the cyanobacterium Nostoc ellipsosporum, specifically recognizes N-glycans of the high-mannose type occurring on the surface of hemagglutinin from influenza virus, gp120 from human immunodeficiency virus 1 (HIV-1) and spike protein S from SARS-CoV and SARS-CoV-2.In addition, an engineered recombinant cyanovirin-N (CV-N) domain-swapped dimer with enhanced binding capacities towards SARS-CoV-2 showed increased binding affinity to the highly Nglycosylated spike protein and hemagglutinin.These engineered CV-N dimers with enhanced binding capacities could be used to improve the neutralization ability of the lectin towards pathogenic enveloped viruses by reducing both the internalization and the spreading of the viruses.However, the antiviral activity of lectins is not limited to hampering or preventing the recognition and subsequent anchorage of the viral particles to the host cells.The Original Research article of Vanhulle et al., brings interesting insights into the antiviral activity of the stinging nettle (Urtica dioica) lectin UDA, a small monomeric lectin with a specificity for
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biotechnology, Ghent University, Ghent, Belgium.
- Pharmadev, Université Toulouse III Paul Sabatier, Toulouse, France.
Zitieren
APA
Van Damme, E. J. M., & Rougé, P. (2023). Editorial: Lectins from plants, algae, fungi, bacteria and animal therapeutic tools for SARS-CoV-2 and other pathogenic enveloped viruses, in a “one-health” perspective. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2023.1139691
Vancouver
Van Damme EJM, Rougé P. Editorial: Lectins from plants, algae, fungi, bacteria and animal therapeutic tools for SARS-CoV-2 and other pathogenic enveloped viruses, in a “one-health” perspective. Frontiers in Cellular and Infection Microbiology. 2023. doi:10.3389/fcimb.2023.1139691
BibTeX
@article{VanDamme2023,
author = {Van Damme, Els J M and Rougé, Pierre},
title = {Editorial: Lectins from plants, algae, fungi, bacteria and animal therapeutic tools for SARS-CoV-2 and other pathogenic enveloped viruses, in a “one-health” perspective},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2023},
doi = {10.3389/fcimb.2023.1139691}
}
EUVIMED